ANDA 78263, held by Lupin Ltd. Perindopril Erbumine.
As of Nov 16, 2026, ANDA 78263 (Perindopril Erbumine), held by Lupin Ltd, was first approved by FDA on Jan 27, 2010, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 27, 2010 | Original application | Approved | None posted |
| Perindopril Erbumine2MG · tablet;oral | Perindopril Erbumine | Discontinued |
| Perindopril Erbumine4MG · tablet;oral | Perindopril Erbumine | Discontinued |
| Perindopril Erbumine8MG · tablet;oral | Perindopril Erbumine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters